INS and Hyperinsulinemia: Evidence from in vitro and in vivo experimental studies has shown that insulin, it’s analogs and oral insulin secretagogues (such as sulfonylureas), which may contribute to hyperinsulinemia, are suggested to increase the incidence and progression of cancer13.